Point of care tests for early medical abortion management
Treatments studied
Part of Women’s health & pregnancy clinical trials.
This trial tests if a rapid blood test can replace ultrasound for women who want a very early medical abortion (before 6 weeks). It aims to make care simpler and faster.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a positive pregnancy test.
- You are less than 6 weeks pregnant based on the date of your last period.
- An ultrasound does not show a pregnancy inside the womb.
- You have no signs or high risk of an ectopic pregnancy (pregnancy outside the womb).
- You want to have a very early medical abortion.
- You can attend follow-up visits and give two blood samples.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares different treatment methods for early missed abortion (when a pregnancy ends but the tissue doesn't pass on its own) to see which works best in real-world settings. It may help you and your doctor choose the safest and most effective option.
This trial tests two different medicines (Mifepristone vs Misoprostol) to see which works better for ending a pregnancy in the second trimester (12–16 weeks). It is for people who are pregnant with one baby and have no major health issues that could affect safety.
This trial is testing a new way to manage gynecological follow-up after an emergency visit using a smartphone app instead of in-person visits. It may be a good fit if you had a specific gynecologic condition mentioned above and can use a digital app.
This trial tests a new point-of-care blood test (ROM-Plus) that helps doctors quickly figure out what's causing vaginal bleeding in early pregnancy when the location of the pregnancy is unclear. The test may help avoid unnecessary procedures and get you the right care faster.
This study tests a non-invasive way to monitor pregnancies that may be at risk for miscarriage. It might help detect problems early so you and your doctor can act.
This trial studies a medicine-product made from conception tissue (from an ultrasound-guided manual vacuum aspiration procedure) for people with an early miscarriage or termination. It may help researchers understand whether this approach is safe and potentially beneficial for recovery, but eligibility depends on specific medical and procedural factors.
Hear when a new Abortion Early trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.